Multimodal neuroimaging data from a 5-week heart rate variability biofeedback randomized clinical trial

We present data from the Heart Rate Variability and Emotion Regulation (HRV-ER) randomized clinical trial testing effects of HRV biofeedback. Younger (N = 121, ages 18-31, 61 female) and older (N = 72, ages 55-80, 45 female) participants completed baseline magnetic resonance imaging (MRI) including T1-weighted, functional MRI (fMRI), pulsed continuous arterial spin labeling (PCASL), and proton magnetic resonance spectroscopy (1H MRS). They also completed an emotion regulation task during fMRI. During fMRI scans, physiological measures (blood pressure, pulse, respiration, and end-tidal CO2) were continuously acquired. Participants were randomized to either increase heart rate oscillations or decrease heart rate oscillations during daily sessions. After 5 weeks of HRV biofeedback, they repeated the baseline measurements in addition to a few new measures (ultimatum game fMRI, training mimicking during blood oxygen level dependent (BOLD) and PCASL fMRI). Participants also wore a wristband sensor to estimate sleep time. Psychological assessment comprised three cognitive tests as well as ten questionnaires related to emotional well-being. Data is publicly available via the OpenNeuro data sharing platform.